Preferred Label : doxorubicin hydrochloride;

UMLS semantic type : T109 - Organic Chemical; T121 - Pharmacologic Substance;

CAS number : 25316-40-9; 82F2G7BL4E;

Codes EINECS : 246-818-3;

Is substance : O;

UNII : 82F2G7BL4E;

InChIKey : MWWSFMDVAYGXBV-RUELKSSGSA-N;

Details


Main resources

You can consult :


https://www.ema.europa.eu/en/medicines/human/EPAR/celdoxome-pegylated-liposomal
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
doxorubicin hydrochloride
doxorubicin hydrochloride
adult
breast neoplasms
neoplasm metastasis
ovarian neoplasms
sarcoma, kaposi
multiple myeloma
Pegylated Liposomal Doxorubicin Hydrochloride
Pegylated Liposomal Doxorubicin Hydrochloride
antibiotics, antineoplastic
antibiotics, antineoplastic
infusions, intravenous
doxorubicin
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical

---
https://www.has-sante.fr/portail/jcms/c_2856030/fr/myocet
2018
false
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
breast cancer
neoplasm metastasis
Breast cancer metastatic
treatment outcome
doxorubicin hydrochloride
doxorubicin
antibiotics, antineoplastic
adult
doxorubicin hydrochloride
antibiotics, antineoplastic
breast neoplasms
doxorubicin
doxorubicin

---
http://www.has-sante.fr/portail/jcms/c_2637487/fr/caelyx-sarcome-de-kaposi
2016
false
false
false
France
French
evaluation of the transparency committee
antibiotics, antineoplastic
treatment outcome
infusions, intravenous
doxorubicin
liposomal doxorubicin
doxorubicin hydrochloride
hiv infections
AIDS-Related Kaposi Sarcoma
Tumor Progression
disease progression
sarcoma, kaposi
doxorubicin
polyethylene glycols
doxorubicin

---
http://www.has-sante.fr/portail/jcms/c_2637484/fr/caelyx-cancer-du-sein
2016
false
false
false
France
French
evaluation of the transparency committee
neoplasm metastasis
treatment outcome
doxorubicin hydrochloride
Stage IV Breast Cancer AJCC v6 and v7
infusions, intravenous
antibiotics, antineoplastic
doxorubicin
doxorubicin hydrochloride
antibiotics, antineoplastic
survival analysis
breast neoplasms
doxorubicin
doxorubicin

---
http://www.has-sante.fr/portail/jcms/c_2620027/fr/caelyx
http://www.has-sante.fr/portail/jcms/c_808801/caelyx
2016
false
France
French
evaluation of the transparency committee
Bortezomib
Malignant neoplasm aggravated
polyethylene glycols
polyethylene glycols
doxorubicin hydrochloride
doxorubicin hydrochloride
liposomal doxorubicin
liposomal doxorubicin
doxorubicin
infusions, intravenous
doxorubicin
antineoplastic combined chemotherapy protocols
multiple myeloma
antibiotics, antineoplastic
treatment outcome
survival analysis
doxorubicin
antibiotics, antineoplastic

---
http://www.has-sante.fr/portail/jcms/c_2629893/fr/caelyx-cancer-ovarien
http://www.has-sante.fr/portail/jcms/c_2629893/fr/caelyx-doxorubicine-liposomale-pegylee-cytotoxique-cancer-de-l-ovaire
2016
false
France
French
Advanced Malignant Neoplasm
ovarian neoplasms
evaluation of the transparency committee
guidelines for drug use
treatment outcome
survival analysis
polyethylene glycols
doxorubicin
doxorubicin
antineoplastic agents
liposomal doxorubicin
liposomes
doxorubicin
doxorubicin hydrochloride

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66977420
2012
France
summary of product characteristics
package leaflet
doxorubicin hydrochloride
doxorubicin

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66959269
2012
France
summary of product characteristics
package leaflet
doxorubicin hydrochloride
doxorubicin

---
https://www.ema.europa.eu/medicines/human/EPAR/Caelyx
2012
United Kingdom
French
English
syndication feed
polyethylene glycols
polyethylene glycols
doxorubicin
doxorubicin hydrochloride
doxorubicin hydrochloride
liposomal doxorubicin
liposomal doxorubicin
doxorubicin
antibiotics, antineoplastic
breast neoplasms
neoplasm metastasis
ovarian neoplasms
sarcoma, kaposi
doxorubicin
antibiotics, antineoplastic
multiple myeloma
treatment outcome
drug evaluation
drug approval
drug labeling
infusions, intravenous
drug interactions
pregnancy
breast feeding
liposomes
doxorubicin
drug evaluation
summary of product characteristics
package leaflet

---
http://www.has-sante.fr/portail/jcms/c_825465/caelyx-doxorubicine-liposomale-pegylee-anthracycline
http://www.has-sante.fr/portail/jcms/c_825463/synthese-d-avis-caelyx-ct-6273
http://www.has-sante.fr/portail/jcms/c_809258/caelyx-ct-6273
2009
false
France
French
Bortezomib
antineoplastic combined chemotherapy protocols
polyethylene glycols
doxorubicin
liposomal doxorubicin
doxorubicin hydrochloride
doxorubicin
antibiotics, antineoplastic
multiple myeloma
antineoplastic agents
liposomes
doxorubicin
guidelines for drug use
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_244833
2003
France
French
polyethylene glycols
doxorubicin
doxorubicin
antineoplastic agents
liposomal doxorubicin
liposomes
doxorubicin
doxorubicin hydrochloride
guidelines for drug use

---
Nous contacter.
24/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.